Aclaris Therapeutics, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aclaris Therapeutics, Inc. for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 8,297 | 0 | 24,892 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 20,600 | 0 | 41,200 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 28,400 | 0 | 28,400 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Option Exercise | A | 24.06 | 99,500 | 2,393,970 | 99,500 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 23.25 | 2,280 | 53,010 | 108,492 | 110.8 K to 108.5 K (-2.06 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 8,297 | 0 | 110,772 | 102.5 K to 110.8 K (+8.10 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Payment of Exercise | F | 24.06 | 5,660 | 136,180 | 102,475 | 108.1 K to 102.5 K (-5.23 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Gordon David N. | Chief Medical Offic ... | Buy | M | 0.00 | 20,600 | 0 | 108,135 | 87.5 K to 108.1 K (+23.53 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 6,637 | 0 | 19,914 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 17,175 | 0 | 34,350 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 28,400 | 0 | 28,400 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 24.06 | 99,500 | 2,393,970 | 99,500 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 23.25 | 1,906 | 44,315 | 143,618 | 145.5 K to 143.6 K (-1.31 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 6,637 | 0 | 145,524 | 138.9 K to 145.5 K (+4.78 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 24.06 | 4,934 | 118,712 | 138,887 | 143.8 K to 138.9 K (-3.43 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 17,175 | 0 | 143,821 | 126.6 K to 143.8 K (+13.56 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,297 | 0 | 24,892 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 25,750 | 0 | 51,500 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 0.00 | 33,200 | 0 | 33,200 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 24.06 | 116,000 | 2,790,960 | 116,000 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 23.25 | 2,844 | 66,123 | 239,059 | 241.9 K to 239.1 K (-1.18 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 8,297 | 0 | 241,903 | 233.6 K to 241.9 K (+3.55 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 24.06 | 7,333 | 176,432 | 233,606 | 240.9 K to 233.6 K (-3.04 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 25,750 | 0 | 240,939 | 215.2 K to 240.9 K (+11.97 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 18,253 | 0 | 54,762 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 96,150 | 0 | 192,300 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 73,100 | 0 | 73,100 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 24.06 | 255,800 | 6,154,548 | 255,800 | |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 23.25 | 7,982 | 185,582 | 1,222,427 | 1.2 M to 1.2 M (-0.65 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 18,253 | 0 | 1,230,409 | 1.2 M to 1.2 M (+1.51 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 24.06 | 39,792 | 957,396 | 1,212,156 | 1.3 M to 1.2 M (-3.18 %) |
Mar 03 2021 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 96,150 | 0 | 1,251,948 | 1.2 M to 1.3 M (+8.32 %) |